Clinical relapses of multiple sclerosis are associated with 'novel' valleys in natural killer cell functional activity
- PMID: 14644036
- DOI: 10.1016/j.jneuroim.2003.10.001
Clinical relapses of multiple sclerosis are associated with 'novel' valleys in natural killer cell functional activity
Abstract
Natural killer (NK) cells are implicated in the pathogenesis of multiple sclerosis (MS). Nine relapsing-remitting MS (RRMS) patients along with age, sex, and NK responder status matched controls were studied serially. Although the average NK cell functional activity (FA) was not significantly different between both groups, four clinical relapses in RRMS patients were associated with the development of 'novel' valleys in FA. These valleys are of greater depth and duration than cyclical valleys observed in both RRMS and controls, precede the onset of clinical attacks, and are observed in RRMS but not controls. In both RRMS and controls, cyclical peaks and valleys in FA are determined by the number of CD33+, CD3-CD56+, and to a lesser extent CD3+CD56+ cells capable of binding targets and inducing cell-mediated cytotoxicity (CMC). In contrast, 'novel' valleys in FA result from a reduction in the ability of CD3-CD56+ bound to targets to induce CMC. The results suggest that RRMS patients are at greater risk for clinical relapses during 'novel' valleys in FA. Furthermore, these valleys are the result of cells with a NK cell phenotype being unable to deliver a 'lethal' hit to targets.
Similar articles
-
[THE TECHNQUE OF FLOW CYTOMETRY IN EVALUATION OF NK-CELLS AND THEIR ACTIVITY].Klin Lab Diagn. 2015 Nov;60(11):37-44. Klin Lab Diagn. 2015. PMID: 26999864 Review. Russian.
-
The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.Hum Immunol. 2015 May;76(5):385-91. doi: 10.1016/j.humimm.2014.09.021. Epub 2014 Oct 8. Hum Immunol. 2015. PMID: 25305457 Review.
-
Natural killer cells in relapsing-remitting MS: effect of treatment with interferon beta-1B.Neurology. 1999 Jan 15;52(2):351-9. doi: 10.1212/wnl.52.2.351. Neurology. 1999. PMID: 9932956 Clinical Trial.
-
A role for natural killer cells in the immunopathogenesis of multiple sclerosis.J Neuroimmunol. 1998 Jun 15;86(2):123-33. doi: 10.1016/s0165-5728(98)00014-9. J Neuroimmunol. 1998. PMID: 9663557
-
Natural killer cells in peripheral blood after autologous bone marrow transplantation: a combined phenotypic and functional study.Nat Immun. 1995;14(3):164-72. Nat Immun. 1995. PMID: 8832900
Cited by
-
The Impact of Cytomegalovirus Infection on Natural Killer and CD8+ T Cell Phenotype in Multiple Sclerosis.Biology (Basel). 2024 Feb 28;13(3):154. doi: 10.3390/biology13030154. Biology (Basel). 2024. PMID: 38534424 Free PMC article.
-
A Noncanonical CD56dimCD16dim/- NK Cell Subset Indicative of Prior Cytotoxic Activity Is Elevated in Patients with Autoantibody-Mediated Neurologic Diseases.J Immunol. 2024 Mar 1;212(5):785-800. doi: 10.4049/jimmunol.2300015. J Immunol. 2024. PMID: 38251887
-
Expansion of a novel population of NK cells with low ribosome expression in juvenile dermatomyositis.Front Immunol. 2022 Oct 31;13:1007022. doi: 10.3389/fimmu.2022.1007022. eCollection 2022. Front Immunol. 2022. PMID: 36389718 Free PMC article.
-
A Novel Potential Role for Monocytes Revealed by Single Cell Analysis of Immunotherapy Induced Immune Related Adverse Events.Cancers (Basel). 2022 Nov 2;14(21):5407. doi: 10.3390/cancers14215407. Cancers (Basel). 2022. PMID: 36358824 Free PMC article.
-
Alterations of NK Cell Phenotype During Pregnancy in Multiple Sclerosis.Front Immunol. 2022 Jul 4;13:907994. doi: 10.3389/fimmu.2022.907994. eCollection 2022. Front Immunol. 2022. PMID: 35860238 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials